Revolution Medicines, Inc.
RVMD
Classement en actions
#587
Revolution Medicines, Inc. is a precision oncology firm operating in the... Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The company's portfolio also features RMC-5845, a selective inhibitor designed to target SOS1, a protein responsible for activating RAS within cells, and RMC-5552, a highly selective inhibitor for hyperactive mTORC1 signaling found in cancerous cells. Further expanding its therapeutic arsenal, Revolution Medicines is advancing RMC-6291, which selectively inhibits mutated forms of KRASG12C(ON) and NRASG12C(ON). Another promising compound, RMC-6236, specifically targets and inhibits a range of active RAS(ON) variants. Its research efforts also encompass other active RAS inhibitors aimed at KRASG13C(ON) and KRASG12D(ON) mutations. Revolution Medicines has established a collaborative partnership with Sanofi to research and develop SHP2 inhibitors, a collaboration that includes the development of RMC-4630. Established in 2014, Revolution Medicines, Inc. operates from its corporate headquarters situated in Redwood City, California.
Prix de l'action
$189.29
Capitalisation boursière
$40.57B
Changement (1 jour)
-2.57%
Changement (1 an)
257.28%
Pays
US
Échange Revolution Medicines, Inc. (RVMD)
Catégorie
Healthcare
Historique du prix de l'action pour Revolution Medicines, Inc. (RVMD)
Prix de clôture le plus élevé : $194.01 le 2026-10-01
Prix de clôture le plus bas : $30.68 le 2020-02-01
Prix de clôture le plus bas : $30.68 le 2020-02-01
Historique du prix de l'action de Revolution Medicines, Inc. de 2020 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 73.05% |
| 2025 | 72.22% |
| 2024 | 75.37% |
| 2023 | 10.12% |
| 2022 | -8.93% |
| 2021 | -38.16% |
| 2020 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $532.09 | 24.77% |
US
|
|
| $236.63 | 781.30% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $889.94 | 9.31% |
NL
|
|
| $291.42 | 2.39% |
BE
|
